In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered Imdelltra achieved a statistically ...

The poster presented data from AUTX-703, a potent, selective and orally bioavailable heterobifunctional degrader of KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung ...

Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

Lung cancer is a disease in which cancerous cells form in the tissues around and inside the lung. There are various types of this disease. Non-small cell lung cancer (NSCLC) is a disease where cancer ...

Merck’s MRK stock declined 2% on Monday after Summit ... as a first-line treatment for PD-L1-positive advanced non-small cell lung cancer (NSCLC). The study was conducted in China with Summit ...